Cytosorbents (CTSO) Gross Profit Growth (3y) (2014 - 2026)
Cytosorbents (CTSO) Gross Profit Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 184.08 Bn | 176.78 Bn | 6.27 Bn | 5.02% |
| 2 | Stryker | 128.96 Bn | 126.08 Bn | 3.81 Bn | 8.10% |
| 3 | Medtronic | 108.90 Bn | 99.68 Bn | 6.41 Bn | 4.81% |
| 4 | Boston Scientific | 68.58 Bn | 67.13 Bn | 3.61 Bn | 15.44% |
| 5 | Edwards Lifesciences | 48.33 Bn | 44.66 Bn | 1.29 Bn | 9.03% |
| 6 | Dexcom | 28.45 Bn | 27.33 Bn | 750.30 Mn | 17.49% |
| 7 | GE HealthCare Technologies | 28.36 Bn | 26.08 Bn | 1.98 Bn | 1.49% |
| 8 | Smith & Nephew | 26.96 Bn | 26.38 Bn | - | - |
| 9 | Koninklijke Philips | 25.43 Bn | 22.31 Bn | 2.07 Bn | 3.15% |
| 10 | Cytosorbents | 21.97 Mn | 17.17 Mn | 6.13 Mn | 3.96% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.96% |
| Dec 31, 2025 | 5.73% |
| Sep 30, 2025 | 22.60% |
| Jun 30, 2025 | 11.28% |
| Mar 31, 2025 | -1.09% |
| Dec 31, 2024 | -6.53% |
| Sep 30, 2024 | -10.36% |
| Jun 30, 2024 | -11.29% |
| Mar 31, 2024 | -4.32% |
| Dec 31, 2023 | -17.41% |
| Sep 30, 2023 | -9.86% |
| Jun 30, 2023 | -2.76% |
| Mar 31, 2023 | -4.80% |
| Dec 31, 2022 | 2.57% |
| Sep 30, 2022 | -6.31% |
| Jun 30, 2022 | 3.98% |
| Mar 31, 2022 | 22.92% |
| Dec 31, 2021 | 24.20% |
| Sep 30, 2021 | 25.52% |
| Jun 30, 2021 | 32.88% |